Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Owkin
CRO
Owkin, Servier ink oncology trial and discovery deal
Owkin has signed a pact with Servier to license Owkin’s AI scientist across Servier’s oncology discovery and trial operations.
Will Maddox
Sep 11, 2026 2:01pm
AstraZeneca pens agentic AI licensing deal with Owkin
May 13, 2026 2:06am
Merck taps Owkin AI to boost microsatellite tests of GI cancers
Dec 19, 2023 10:37am
White House expands Cancer Moonshot with screening, AI programs
Feb 2, 2023 5:22pm
Urica unites around new CEO Kranzler—Chutes & Ladders
Oct 7, 2022 9:56am
Homology shakes up leadership—Chutes & Ladders
Sep 9, 2022 9:30am
